The forecasted use of antiinfective medicine in Türkiye is expected to show a slight decline from 34.1 units per thousand persons per day in 2024 to 33.5 units in 2028. The year-on-year variation indicates a steady drop of approximately -0.3% annually, amounting to a cumulative average growth rate (CAGR) over the five years of -0.4%.
Key variations:
- 2024 to 2025: -0.3%
- 2025 to 2026: -0.6%
- 2026 to 2027: -0.3%
- 2027 to 2028: -0.6%
Future trends to watch for include potential impacts of new public health policies aimed at reducing antibiotic resistance, shifts in healthcare practices, and the influence of emerging infectious diseases. Monitoring how these factors affect the demand for antiinfective medicines will be crucial in the coming years.
